Wednesday, August 05
While the Sensex and Nifty tumbled around 2% each after the Union Budget was shorn of high-impact immediate measures, leading brokerages are rushing to position portfolios ahead of what Goldman Sachs projects as "high-teen full-year returns" driven by an underlying earnings recovery. From defence contractors to data centre developers, analysts are racing to identify winners in a fiscal blueprint that prioritises strategic infrastructure over immediate consumption stimulus.The Budget's sharpest edge cuts towards defence spending, set to surge 17.6% year on year to Rs 2.2 lakh crore in FY27, according to Motilal Oswal, which noted the allocation "cognises the prevalent geopolitical strife." This outpaces overall capital expenditure growth of 11.5% to Rs 12.2 lakh crore, signalling where the
In the wake of a record crash in gold and silver prices, the BSE has imposed a 20% circuit limit on Gold and Silver ETFs. For the current trading session, ETF prices will be anchored to the previous day’s NAV (T-1 NAV), with transactions allowed only within a ±20% band. The move aims to curb excessive intraday volatility and protect investors from abrupt price swings.“In view of the volatility in underlying Gold & Silver prices, Reference Price for Gold and Silver ETFs traded on the Exchange shall be based on the T- 1 NAV as published by the respective Mutual Funds / Asset management Companies. Accordingly, the prescribed price band of +/- 20% shall be applicable to the said T- 1 NAV price for trading purposes,” BSE said in a circular earlier today.This comes after Gold and silv
Shares of Sun Pharmaceutical Industries rallied as much as 3.78%, touching an intraday high of Rs 1,655.70 on the NSE during Sunday’s trading session. The surge followed the company's strong quarterly performance, which boosted investor confidence.Sun Pharma reported a consolidated net profit of Rs 3,369 crore for Q3 FY26, up 16% from Rs 2,903 crore in the same quarter last year. Revenue from operations also grew 13% YoY to Rs 15,520 crore, compared with Rs 13,675 crore in Q3 FY25. The company’s EBITDA rose 23.4% year-on-year to Rs 4,948.4 crore, with margins improving to 31.9% from 29.3% previously, signalling better profitability and operational efficiency.Sun Pharma dividend updateSun Pharma announced an interim dividend of Rs 11 per equity share of Re 1 each for FY26. The record da
Bitcoin hovers around the $78,800 level, down by 6.04% in the past 24 hours, as the crypto market remains under pressure due to the Fed leadership change, geopolitical and macroeconomic developments keep investors cautious. The cryptocurrency was trading at $78,833.On Friday, Bitcoin fell to as low as $81,104, the lowest since November 21, 2025, while the U.S. dollar gained after former Federal Reserve Governor Kevin Warsh was selected as the next Fed chair.Also Read | Gold ETFs crash 16% on stronger dollar, silver ETFs follow suit. What should investors do?Ethereum slipped 9.21% in the past 24 hours to trade at the level of $2,449. Among the major altcoins, BNB, XRP, Solana, Tron, Dogecoin, Cardano, and Hyperliquid fell upto 11% in the past 24 hours. The global crypto market capita
